C-QUR™ Mesh, pronounced “Secure,” is a polypropylene hernia mesh coated in Omega-3 fatty acid (fish oil). The fish oil coating is advertised as an anti-inflammatory “adhesion barrier” that helps prevent scar-tissues from sticking organs together during healing.
However, a growing number of lawsuits have been filed by people who developed pain, inflammation, adhesions, infections, foreign body reactions, and other side effects from the fish oil coating on C-QUR hernia mesh.
One of the most recent lawsuits was filed by Theresa Callaway, a woman from Georgia who was implanted with C-QUR Edge mesh for an abdominal hernia in 2008. Her hernia soon returned, and doctors implanted another C-QUR patch.
Over the next few years, she developed chronic pain, nausea, vomiting, infections, and other life-threatening health problems. In 2014 and 2015, surgeons said C-QUR mesh was “bunched up in layers” or “folded up” and causing pain when it poked into open wounds.
The lawsuit was filed on October 31 in the U.S. District Court for the Northern District of Georgia — Case No. 1:16-cv-04068.
In another case report, a 61 year-old woman developed chronic pain and a hard lump on on her chest within a few months of being implanted with C-QUR mesh. During surgery to remove the mesh, doctors found “dense adhesive disease around the mesh” due to an inflammatory foreign body reaction.
Atrium Medical Corp. is facing at least 14 lawsuits from people who were injured by C-QUR Mesh, C-QUR TacShield, and the C-QUR V-Patch. The company is accused of selling dangerous implants and failing to warn about risks.
On November 1, lawyers for Atrium said all of the lawsuits should be centralized in one federal court in New Hampshire. This “mass-tort” or Multi-District Litigation (MDL) is designed to help lawyers coordinate the discovery process, trials, and settlement negotiations.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) will hear oral arguments on the proposed C-QUR mesh MDL in a meeting on December 3 in New Orleans, Louisiana.